Metronidazol Actavis

Metronidazole, the active ingredient in Metronidazol Actavis, is a nitroimidazole antibiotic presented as an oral tablet for systemic use. It is employed to treat infections caused by anaerobic bacteria and certain protozoa in adult and pediatric patients when indicated by a healthcare professional. Treatment is provided under appropriate clinical guidance and after confirming microbial susceptibility.

GNH USA supplies Metronidazol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics, and health‑care institutions across multiple regions with reliable quality assurance worldwide.

Metronidazole is used to treat infections caused by anaerobic bacteria and protozoa. - Bacterial vaginosis: eradicates the anaerobic bacteria responsible for the condition, relieving symptoms. - Trichomoniasis: eliminates Trichomonas vaginalis, resolving infection and preventing transmission. - Amoebiasis: destroys Entamoeba histolytica trophozoites, treating intestinal and extra‑intestinal disease. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, skin and soft‑tissue infections. - Clostridioides difficile infection: reduces toxin‑producing bacteria, aiding clinical recovery.

Metronidazole may cause a variety of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools, sometimes watery. - Headache: mild to moderate headache. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Severe allergic reactions: rash, swelling, anaphylaxis. - Stevens‑Johnson syndrome: severe skin eruption. - Liver toxicity: elevated enzymes or hepatitis. - Peripheral neuropathy: tingling or numbness in extremities. - Pseudomembranous colitis: severe colonic inflammation.

Before prescribing Metronidazol Actavis, clinicians should consider several safety aspects. - Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: excreted in milk; evaluate alternatives. - Renal impairment: dose adjustment may be required. - Alcohol consumption: may cause a disulfiram‑like reaction. - Drug interactions: review concomitant medications for potential effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazol Actavis can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Disulfiram: concurrent use may cause severe reactions. - Alcohol: can precipitate a disulfiram‑like response. - Warfarin: may increase anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Lithium: metronidazole may raise lithium levels. - Phenytoin: may reduce metronidazole concentrations. - Cimetidine: can increase metronidazole plasma levels.